Is IVUS Guided PCI a Common Technique?

We all know the benefits of ultravascular ultrasound (IVUS) in the development of percutaneous coronary intervention, such as more accurate vessel measurement, improved stent expansion and apposition, and complication identification. This is why the use of IVUS is a class IIa recommendation in AHA and ESC guidelines. 

¿Es frecuente el uso de IVUS para guiar la ATC?

The aim of this retrospective study was to assess the use of IVUS in complex PCI and to compare mortality and the need for target vessel revascularization in patients with IVUS guided PCI vs unguided PCI. 

Complex lesions included bifurcations, chronic total occlusion, unprotected left main, long lesions >33 mm, instent restenosis, severe calcifications, multivessel PCI, and multiple stenting.  

Primary end point was mortality and target vessel revascularization at 2 years. 

In 44305 patients receiving complex lesion PCI, 13.9% of procedures were guided by IVUS: 33% of these were on left main lesions, 15% multiple stenting, 14% multivessel PCI, and 14% long lesions. The use of IVUS guided PCI grew from 13% in 2014 to 16% in 2018.

Read also: High Risk of Bleeding after PCI: More Evidence for Short DAPT.

Patients in the IVUS guided arm more often presented ejection fraction >50%, with left main and proximal descending artery compromise, and the use of drug eluting stents, while also less frequently presented recent MI, right coronary artery compromise and lesions in small and tortuous vessels. 

As regards results, IVUS guided PCI showed significantly lower mortality and less treated vessel revascularization at followup. 

Conclusion

The use of IVUS in complex lesion PCI occurs in low numbers despite the considerable evidence in support of its use. Treating these lesions with IVUS showed reduced morality and target vessel revascularization at midterm compared against PCI without IVUS guidance.  

Dr. Andrés Rodríguez
Member of the Editorial Board of SOLACI.org.

Original Title: Percutaneous Coronary Intervention With and Without Intravascular Ultrasound for Patients With Complex Lesions: Utilization, Mortality, and Target Vessel Revascularization.

Reference: Edward L. Hannan et al Circ Cardiovasc Interv. 2022;15:e011687.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...